Roche Holding AGXSWX:ROP +2.09%79 OCF Margin % is 37.30% as of Dec. 2025, which is 16% above its 10-year median of 32.02. GuruFocus rates XSWX:ROP with a GF Score™ of 79/100 and a GF Value™ of CHF264.69 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Roche Holding AG ranks better than 92.7% on this metric.
The historical rank and industry rank for Roche Holding AG's OCF Margin % or its related term are showing as below:
XSWX:ROP'
s OCF Margin % Range Over the Past 10 Years
Min: 26.63 Med: 32.02 Max: 36.42
Current: 29.76
During the past 13 years, the highest OCF Margin % of Roche Holding AG was 36.42%. The lowest was 26.63%. And the median was 32.02%.
XSWX:ROP's OCF Margin % is ranked better than 92.7% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs XSWX:ROP: 29.76
Roche Holding AG OCF Margin % Related Terms
Roche Holding AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for Roche Holding AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ROP vs LLY, JNJ, ABBV: OCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Roche Holding AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Roche Holding AG OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Roche Holding AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Roche Holding AG (XSWX:ROP) has a OCF Margin % of 37.30% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Roche Holding AG and its competitors. This is 16% above median its historical median of 32.02. Over the past decade, Roche Holding AG's OCF Margin % has ranged from 26.63 to 36.42. According to the industry distribution chart, Roche Holding AG ranks #70 out of 959 companies in the Drug Manufacturers industry, placing it in the top 7.3%.
Is Roche Holding AG's OCF Margin % too high?
Roche Holding AG's current OCF Margin % of 37.30% is 16% above median its 10-year median of 32.02. Over the past 10 years, this metric has ranged from a low of 26.63 to a high of 36.42. The Drug Manufacturers industry median OCF Margin % is 9.95. Roche Holding AG's value of 37.30% is 274.9% above this industry median. Based on the distribution chart, Roche Holding AG ranks #70 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Roche Holding AG has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Roche Holding AG ranks #70 out of 959 companies for OCF Margin %. This places Roche Holding AG in the top 7% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Roche Holding AG's value of 37.30% is 274.9% above this benchmark. Historically, Roche Holding AG's own OCF Margin % has ranged from 26.63 to 36.42 over the past decade. While the company's 10-year median is 32.02 vs. the industry median of 9.95, Roche Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Roche Holding AG's current OCF Margin % of 37.30% is 274.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Roche Holding AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Roche Holding AG's current OCF Margin % is 37.30%, which is 16% above median its own 10-year median of 32.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:ROP) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF264.69, compared to a current price of CHF332.00 — trading 25.4% above its estimated fair value. The current OCF Margin % is 37.30%, which is 16% above median its 10-year median of 32.02 and 274.9% above the Drug Manufacturers industry median of 9.95. Roche Holding AG's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Roche Holding AG (XSWX:ROP), the current OCF Margin % is 37.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?
Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued.
The current stock price of CHF332.00 is trading 25.4% above its estimated GF Value™ of CHF264.69.
GuruFocus considers Roche Holding AG to be Modestly Overvalued.
Key valuation signals for XSWX:ROP:
OCF Margin %: 37.30% (16% above median its 10-year median of 32.02)
GF Value™: CHF264.69 vs. price of CHF332.00 (25.4% above fair value)
Industry Position: 274.9% above the Drug Manufacturers median (#70 of 959)
No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
79GF Score
Get the complete analysis for XSWX:ROP
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ROP has been successfully added to your 
